Larvol Delta - Clarity-Pharmaceuticals-Announces-the-US-FDA-Grants-Rare-Paediatric-Disease-Designation-to-64CuSARTATE-a-diagnostic-for-the-clinical-management-of-neuroblastoma

Sartate (67Cu MeCOSar octreotate) - Clarity Pharma

https://www.prnewswire.com/news-releases/clarity-pharmaceuticals-announces-the-us-fda-grants-rare-paediatric-disease-designation-to-64cu-sartate-a-diagnostic-for-the-clinical-management-of-neuroblastoma-301126037.html

Sep 9, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next